US Stock MarketDetailed Quotes

ELV Elevance Health

Watchlist
  • 413.650
  • -0.170-0.04%
Close Apr 29 16:00 ET
  • 413.650
  • 0.0000.00%
Post 17:51 ET
93.46BMarket Cap16.10P/E (TTM)

About Elevance Health Company

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Company Profile

SymbolELV
Company NameElevance Health
Listing DateOct 30, 2001
Founded1944
CEOMs. Gail Koziara Boudreaux
MarketNYSE
Employees104200
Fiscal Year Ends12-31
Address220 Virginia Avenue
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46204
Phone1-833-401-1577

Company Executives

  • Name
  • Position
  • Salary
  • Gail Koziara Boudreaux
  • President, Chief Executive Officer and Director
  • 20.47M
  • Ronald W. Penczek
  • Chief Accounting Officer and Controller
  • --
  • Ratnakar V. Lavu
  • Executive Vice President and Chief Digital and Information Officer
  • --
  • Mark B. Kaye
  • Executive Vice President and Chief Financial Officer
  • 6.87M
  • Felicia F Norwood
  • Executive Vice President and President, Government Health Benefits
  • 6.29M
  • Peter D. Haytaian
  • Executive Vice President; President of Carelon and CarelonRx
  • 6.35M
  • Charles Morgan Kendrick, Jr
  • Executive Vice President and President, Commercial and Specialty Health Benefits
  • 5.79M
  • Elizabeth E. Tallett
  • Chairman of the Board
  • 605.00K
  • Susan Dodson DeVore
  • Independent Director
  • 345.00K
  • Deanna D. Strable-Soethout
  • Independent Director
  • 345.00K
  • Ryan M. Schneider
  • Independent Director
  • 376.37K
  • Robert L. Dixon, Jr
  • Independent Director
  • 352.61K
  • Ramiro G. Peru
  • Independent Director
  • 392.61K
  • R. Kerry Clark
  • Independent Director
  • 375.00K
  • Lewis Hay, III
  • Independent Director
  • 345.00K
  • Antonio Fabio Neri
  • Independent Director
  • 352.61K
  • Dr. Bahija Jallal, PhD
  • Independent Director
  • 392.61K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More